It’s time to take a look at where BioLife has been and where it’s headed. This includes some ambitious goals, some practical steps towards solvency and the end result is a platform used around the world to improve biomedical health care and reduce costs.
So far, BioLife has taken its first steps initially planned for in its roadmap:
May 2017 — Channel partnership formed, development of beta version for the patient-facing mobile app
May 2018 — Token holder social media channels launch.
October 2018 — Roadshow commences.
Heading into the future, BioLife plans to move forward step by step and eventually reach over 3 billion users worldwide.
December 2018 — Token generating event, eight-node service agents opened for users to offer offline services.
January 2019 — BioLife service platform completed, data of patients and 80 types of medicines launched, smart contracts implemented, launch of EHRaas, BioLife think tank opens, BioLife deployed in UK and China.
March 2019 — BioLife token holders vote on top issues.
May 2019 — Asset digitization enabled by forming strategic alliances with more high-end biomedical R&D institutions, medicine producers and health service agents.
June 2019 — BioLife token holders vote on newest top issues and previously unresolved issues.
July 2019 — BioLife R&D lab opens, additional validation notes added.
August 2019 — DApp version 2.0 goes live.
April 2020 — DAC created, additional value notes added
June 2020 — BioLife in 4 continents, 3.5 billion end users, high-end health services ecosystem of global circulation fully implemented.
BioLife is in the business of saving lives. By creating the right economic ecosystem to encourage research, reduce costs and make biomedicinal technologies available to everyone, your life is going to be heavily influenced by BioLife.
Want to be part of our journey? Join our Telegram group!
